Logo

cancer panel

Cancer Sequencing Panel Speeds Rapidly Improving, but Clinical Impact Studies Are Needed
Premium

Thermo Fisher Scientific's IonTorrent Genexus platform can provide cancer panel results in about a day, but data on clinical impact of the fast turnaround has not yet been produced.

Illumina, Myriad Genetics Expand Partnership to Bring TSO 500 HRD Assay to US

The firms are creating a CDx alliance to help pursue HRD regulatory approvals for both the MyChoice HRD assay and a future clinical IVD test from Illumina.

Everything Genetic, Berkshire and Surrey Pathology Services Jointly Launch Cancer NGS Service in UK

BSPS will provide cancer sequencing services using two cancer gene panels currently under development at Everything Genetic to customers across the UK.

Thermo Fisher Introduces Homologous Recombination Deficiency Score for Cancer Profiling Assay
Premium

The firm is also bringing its comprehensive genomic profiling assay for cancer to the Ion Torrent Genexus sequencing platform in the first half of 2023.

Next PrecisionFDA Challenge Takes on Indel Calling from Oncopanel Sequencing Data

In a challenge that opens May 2, participants must design indel calling pipelines as the FDA's NCTR looks to close a knowledge gap.

Feb 3, 2022

Illumina, French Hospitals Partner on Cancer Genomic Profiling Study

Aug 5, 2021

NYU Langone Health, Philips Integrate Informatics for FDA-Cleared Cancer Sequencing Panel
Premium

Feb 17, 2021

Exact Sciences Sketches Out Strategy for End-to-End Cancer Testing With Ashion Acquisition
Premium

Feb 16, 2021

Exact Sciences Q4 Revenues up 58 Percent; Company to Acquire Ashion Analytics From TGen

Feb 9, 2021

UK Startup Gabriel Precision Oncology Leans on Congenica to Broaden NGS Use in Cancer Testing
Premium

Dec 28, 2020

M&A Deals in MDx/Omics Research Tools Space Fall 13 Percent in 2020
Premium

Nov 23, 2020

Multigene Panel Germline Testing of Cancer Patients Detects Unexpected Pathogenic Variants
Premium

Sep 24, 2020

Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

Mar 31, 2020

The Decade in Genomics: CRISPR, Single Cells, Long Reads, Clinical and Consumer Applications
Premium

Mar 12, 2020

Thermo Fisher, Janssen Biotech to Develop CDx for Lung Cancer, Other Indications

Feb 13, 2020

Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel

Feb 11, 2020

New Algorithms Unlock Targeted Sequencing on Nanopore Platforms
Premium

Jan 16, 2020

Illumina Targets Single-Cell, Oncology Applications With New NextSeq Platform
Premium

Dec 19, 2019

Guardant Health Liquid Biopsy Test Gets Expanded Medicare Coverage for Solid Tumors

Dec 11, 2019

At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

Dec 6, 2019

Gene Panel Finds Pathogenic Variants Missed by Standard Tests in 5 Percent of Familial Cancer Cases

Sep 24, 2019

Foundation Medicine, Natera to Develop Liquid Biopsy Monitoring Assays

Sep 5, 2019

Large-Scale Multigene Panel Study of Hereditary Cancer Risk Refines Gene Associations
Premium

Jun 20, 2019

On Heels of $200M Cash Infusion, Tempus Enters Major Growth Phase
Premium

Apr 2, 2019

Nordic Countries Invest $19M in Personalized Medicine Research Projects
Premium

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.